Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia.
about
Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Reduced CD62L Expression on T ...... Chronic Myelogenous Leukemia.
@en
Reduced CD62L Expression on T ...... Chronic Myelogenous Leukemia.
@nl
type
label
Reduced CD62L Expression on T ...... Chronic Myelogenous Leukemia.
@en
Reduced CD62L Expression on T ...... Chronic Myelogenous Leukemia.
@nl
prefLabel
Reduced CD62L Expression on T ...... Chronic Myelogenous Leukemia.
@en
Reduced CD62L Expression on T ...... Chronic Myelogenous Leukemia.
@nl
P2093
P50
P356
P1476
Reduced CD62L Expression on T ...... Chronic Myelogenous Leukemia.
@en
P2093
Andreas Burchert
Dominik Wolf
Frank Giles
Gert J Ossenkoppele
Günther Gastl
Jeroen J W M Janssen
Matthias Baldauf
Peter Valent
Sieghart Sopper
Thomas Ernst
P304
P356
10.1200/JCO.2016.67.0893
P407
P577
2016-11-07T00:00:00Z